Current progress and advances in hepatocellular carcinoma:highlights from 2024 ASCO annual meeting
成远 1朱小东2
扫码查看
点击上方二维码区域，可以放大扫码查看
作者信息
1. 解放军东部战区总医院全军肿瘤中心,江苏 南京 210002
2. 复旦大学附属中山医院肝肿瘤外科,上海 200032
折叠
摘要
2024 年美国临床肿瘤学会(American Society of Clinical Oncology,ASCO)年会于 2024 年 5 月 31 日在美国芝加哥召开.今年大会的主题是"癌症治疗的艺术与科学:从关怀到治愈".本次大会上报道了多项肝细胞癌(hepatocellular carcinoma,HCC)领域的重磅研究,涵盖晚期系统治疗、局部联合系统治疗和围手术期治疗等.部分研究结果将改变临床实践并推动肝癌领域的发展.本文重点介绍大会HCC相关研究结果,探讨HCC的治疗热点、问题和未来发展方向.
Abstract
The 2024 annual meeting of the American Society of Clinical Oncology(ASCO)was held on May 31st,2024,in Chicago,USA.The theme of this year's conference is"The Art and Science of Cancer Care:From Comfort to Cure".This conference reported many im-portant studies in the field of hepatocellular carcinoma(HCC),including advanced systemic therapy,locoregional therapy in combination with systemic therapy,perioperative therapy,etc.These results may change the clinical practice and promote the development of HCC.This article focuses on the research on HCC at the conference and discusses the hot spots,problems,and future directions.
关键词
肝细胞癌/美国临床肿瘤学会/治疗
Key words
hepatocellular carcinoma/American Society of Clinical Oncology/treatment
维普
万方数据